This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
Blood
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Caput luminal fluid
Cauda luminal fluid
Cerebrospinal fluid
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (SW48)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Epidermal melanocyte (HEMa-LP)
Fetal human colon epithelial cell (FHC)
Liver cancer cells (MHCC-97L)
Malignant melanoma cell (A375)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Oral cancer cells (HOC313-LM)
Plasma
Seminal plasma
Serum
By sample status
2 years old
24 hr culture
70 years old
72 hr culture
Colorectal cancer_stage1
Extremely severe hand, foot, and mouth disease
Fetal bovine serum
Healthy_timepoint1
Healthy_timepoint2
Normal
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Transplant islets into mouse xenotransplantation
Transplant islets into mouse xenotransplantation-rejected
Vasectomy
Vasovasostomy
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
ppy-miR-1281
MIMAT0016202
0.0e+0
0.0e+0
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000695_1
37
/
0
/
37
ppy-miR-1281
MIMAT0016202
0.0e+0
0.0e+0
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000695_1
37
/
0
/
37
ppy-miR-1281
MIMAT0016202
0.0e+0
0.0e+0
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000695_1
37
/
0
/
37
ppy-miR-1281
MIMAT0016202
0.0e+0
0.0e+0
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000695_1
37
/
0
/
37
hsa-miR-1281
MIMAT0005939
0.0e+0
1.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000695_1
37
/
0
/
37
ppy-miR-1281
MIMAT0016202
0.0e+0
0.0e+0
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000695_1
37
/
0
/
37
hsa-miR-1281
MIMAT0005939
0.0e+0
4.0e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000695_1
37
/
0
/
37
hsa-miR-1281
MIMAT0005939
0.0e+0
4.9e-5
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000695_1
37
/
0
/
37
ptr-miR-1281
MIMAT0008000
0.0e+0
4.9e-5
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000695_1
37
/
0
/
37
hsa-miR-1281
MIMAT0005939
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000695_1
37
/
0
/
37
ptr-miR-1281
MIMAT0008000
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000695_1
37
/
0
/
37
hsa-miR-1281
MIMAT0005939
3.3e-2
5.0e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000695_1
37
/
0
/
37
hsa-miR-1281
MIMAT0005939
2.2e-2
2.2e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000695_1
37
/
0
/
37
<
[2]